[Biochemical principles of the development of new cardiac drugs of the digitalis type].
作者信息
Repke K R
出版信息
Pharmazie. 1972 Nov;27(11):693-701.
PMID:4265944
Abstract
摘要
相似文献
1
[Biochemical principles of the development of new cardiac drugs of the digitalis type].
Pharmazie. 1972 Nov;27(11):693-701.
2
[Kinetics of cardiac steroids in man and experimental animals].[人体和实验动物中心脏甾体类药物的动力学]
Klin Wochenschr. 1970 Mar 1;48(5):257-70. doi: 10.1007/BF01486434.
3
Biliary excretion of cardiac glycosides.
J Pharmacol Exp Ther. 1973 Sep;186(3):455-62.
4
[Renal elimination kinetics of various several cardiac glycosides].[多种强心苷的肾脏排泄动力学]
Dtsch Med Wochenschr. 1972 Oct 6;97(40):1485-90. doi: 10.1055/s-0028-1107587.
5
[The pharmacology of cardiac glycosides].[强心苷类药物的药理学]
Med Klin. 1971 Apr 16;66(16):583-6.
6
Species difference in duration of action of cardiac glycosides.强心苷作用持续时间的种属差异。
Fed Proc. 1967 Jul-Aug;26(4):1125-30.
7
[Determination of the intestinal absorption of cardiac glycosides by measurement of 3H-labelled glycosides in the portal venous blood and in the intestinal lymph of cats].[通过测量猫门静脉血和肠淋巴液中3H标记的强心苷来测定强心苷的肠道吸收]
Naunyn Schmiedebergs Arch Pharmakol. 1969;264(4):406-19.
8
[Biochemical aspects of digitalis therapy].[洋地黄疗法的生化方面]
Z Gesamte Inn Med. 1971 Feb 1;26(3):Suppl:8-16.
9
[Cumulative effect of cardiac glycosides. (Review)].[强心苷的累积效应。（综述）]
Farmakol Toksikol. 1969 Nov-Dec;32(6):745-6.
10
Digitalis (third of four parts).洋地黄（四分之三部分）。
N Engl J Med. 1973 Nov 15;289(20):1063-72. doi: 10.1056/NEJM197311152892005.
引用本文的文献
1
Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.内源性强心甾体：生理学、药理学及新型治疗靶点。
Pharmacol Rev. 2009 Mar;61(1):9-38. doi: 10.1124/pr.108.000711.
2
Ouabain-receptor interactions in (Na+ plus K+)-ATPase preparations. IV. The molecular structure of different cardioactive steroids and other substances and their affinity to the glycoside receptor.（钠钾）-ATP酶制剂中的哇巴因-受体相互作用。IV. 不同强心甾体及其他物质的分子结构及其对糖苷受体的亲和力。
Naunyn Schmiedebergs Arch Pharmacol. 1974;283(4):335-56. doi: 10.1007/BF00501108.
3
Influence of derivation on the lipophilicity and inhibitory actions of cardiac glycosides on myocardial Na+-K+-ATPase.衍生化对强心苷亲脂性及其对心肌钠钾ATP酶抑制作用的影响。
Br J Pharmacol. 1987 May;91(1):31-8. doi: 10.1111/j.1476-5381.1987.tb08980.x.
4
Lipophilicity and pharmacodynamics of cardiotonic steroids in guinea-pig isolated heart muscle preparations.强心甾类化合物在豚鼠离体心肌制剂中的亲脂性和药效学
Br J Pharmacol. 1988 Feb;93(2):281-8. doi: 10.1111/j.1476-5381.1988.tb11432.x.
5
Correlation between inhibition of (Na+, K+)-membrane-ATPase and positive inotropic activity of cardenolides in isolated papillary muscles of guinea pig.豚鼠离体乳头肌中强心苷对（钠，钾）-膜ATP酶的抑制作用与正性肌力活性之间的相关性。
Naunyn Schmiedebergs Arch Pharmacol. 1978 Aug;304(1):37-44. doi: 10.1007/BF00501375.
6
Cardiac glycosides: prerequisites for the development of new cardiotonic compounds.强心苷：新型强心化合物研发的先决条件。
Experientia. 1977 Jun 15;33(6):697-703. doi: 10.1007/BF01944136.
Zotero 插件